Ipsen Biopharmaceuticals, Inc.
Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we develop and commercialize medicines in three key therapeutic areas –Oncology, Neuroscience and Rare Disease. We work to provide hope for patients whose lives are challenged by difficult-to-treat diseases, including neurological disorders such as certain types of spasticity and cervical dystonia. Our people are driven by a passion to help patients and bring our mission to life every day. We are always ready to listen to—and learn from—patients. Every day, our more than 5,700 employees worldwide, including over 600 in North America, work diligently to improve the lives of patients around the world. For more information please visit www.ipsenus.comdd.